Shrividya Iyer

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text

First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer

Benjamin Solomon, Tony Mok, Dong‐Wan Kim et al. · New England Journal of Medicine · 2014 · 3.2K citations · Full text

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Hope S. Rugo, Richard S. Finn, Véronique Dièras et al. · Breast Cancer Research and Treatment · 2019 · 415 citations · Full text

Economic Burden of Postoperative Ileus Associated With Colectomy in the United States

Shrividya Iyer, W. Brian Saunders, Stephen Stemkowski · Journal of Managed Care Pharmacy · 2009 · 334 citations · Full text

The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study

Shrividya Iyer, Adam Roughley, A. Rider et al. · Supportive Care in Cancer · 2013 · 216 citations

Symptom Burden, Tobacco Control, Cancer Screening +9